UCL has held an independent special inquiry into regenerative medicine research at UCL which was published in full in September 2017.

The panel, chaired by Professor Stephen Wigmore from the University of Edinburgh, carried out a thorough investigation of the involvement of UCL and its personnel in regenerative medicine research but with particular focus on the field of tracheal and large airway tissue engineering. The inquiry made a series of recommendations and UCL is acting upon all of them.

As a world-leading university, UCL takes the integrity of its research very seriously, and we are always seeking to improve our processes and raise our standards. Any research undertaken at UCL is required to conform to the highest legal, ethical and regulatory standards, and we will not hesitate take the necessary action, if and when this falls short.

We are committed to supporting our staff as they continue a wide range of excellent research into regenerative medicine, which has tremendous potential to improve patient outcomes with proper support and governance.

Many of our scientists are leading ground-breaking projects, helping develop new cancer therapies, using artificial intelligence to better predict diseases and innovating new surgical techniques, all of which is transforming the lives of millions of people around the world.

The recommendations made by the independent special inquiry were:

For further information and full access to the published report:

• UCL launches special inquiry into regenerative medicine research - March 2017

• UCL publishes independent report into regenerative medicine research – September 2017

• UCL was also lead author in The Lancet Commission: Stem cells and regenerative medicine’ – October 2017